Reply to 'Comment on 'Efficacy and toxicity of treatment with the anti-CTLA-4 antibody ipilimumab in patients with metastatic melanoma after prior anti-PD-1 therapy''

Affiliations

• ¹ Rockingham General Hospital, Perth, Western Australia, Australia.
• ² School of Medicine and Pharmacology, University of Western Australia, Nedlands, Western Australia, Australia.
• ³ Department of Medical Oncology, Olivia Newton-John Cancer Centre, Austin Hospital, Melbourne, Victoria, Australia.
• ⁴ Olivia Newton-John Cancer Research Institute, Melbourne, Victoria, Australia.
• ⁵ The Christie NHS Foundation Trust and University of Manchester, Manchester, UK.
• ⁶ Royal Marsden Hospital NHS Foundation Trust, London, UK.
• ⁷ Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.
• ⁸ Princess Alexandra Hospital, Greenslopes Private Hospital, Brisbane, Queensland, Australia.
• ⁹ Department of Medical Oncology, Sir Charles Gairdner Hospital, Nedlands, Western Australia, Australia.
• ¹⁰ Westmead Hospital, Sydney, New South Wales, Australia.
• ¹¹ Melanoma Institute Australia, Sydney, New South Wales, Australia.
• ¹² Box Hill Hospital, Melbourne, Victoria, Australia.
• ¹³ University of Sydney, Sydney, New South Wales, Australia.